{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T06:43:10Z","timestamp":1790750590695,"version":"4.1.0"},"reference-count":35,"publisher":"American Medical Association (AMA)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2018.1588","type":"journal-article","created":{"date-parts":[[2018,8,20]],"date-time":"2018-08-20T21:39:55Z","timestamp":1534801195000},"page":"e181588","source":"Crossref","is-referenced-by-count":102,"title":["Changes in Buprenorphine-Naloxone and Opioid Pain Reliever Prescriptions After the Affordable Care Act Medicaid Expansion"],"prefix":"10.1001","volume":"1","author":[{"given":"Brendan","family":"Saloner","sequence":"first","affiliation":[{"name":"Department of Health Policy & Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Levin","sequence":"additional","affiliation":[{"name":"Department of Health Policy & Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsien-Yen","family":"Chang","sequence":"additional","affiliation":[{"name":"Department of Health Policy & Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland"},{"name":"Center for Drug Safety and Effectiveness, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Jones","sequence":"additional","affiliation":[{"name":"National Mental Health and Substance Use Policy Laboratory, Substance Abuse and Mental Health Services Administration, US Department of Health and Human Services, Washington, DC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. Caleb","family":"Alexander","sequence":"additional","affiliation":[{"name":"Center for Drug Safety and Effectiveness, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland"},{"name":"Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland"},{"name":"Division of General Internal Medicine, Johns Hopkins Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2018,8,17]]},"reference":[{"issue":"294","key":"zoi180099r2","first-page":"1","article-title":"Drug overdose deaths in the United States, 1999-2016.","author":"Hedegaard","year":"2017","journal-title":"NCHS Data Brief"},{"issue":"5","key":"zoi180099r6","doi-asserted-by":"publisher","first-page":"642","DOI":"10.2105\/AJPH.2018.304338","article-title":"Impact of Medicaid Expansion on access to opioid analgesic medications and medication-assisted treatment.","volume":"108","author":"Sharp","year":"2018","journal-title":"Am J Public Health"},{"issue":"11","key":"zoi180099r7","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1056\/NEJMp1108649","article-title":"Moving beyond parity\u2014mental health and addiction care under the ACA.","volume":"365","author":"Barry","year":"2011","journal-title":"N Engl J Med"},{"issue":"14","key":"zoi180099r8","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1001\/jama.2015.10345","article-title":"Changes in substance abuse treatment use among individuals with opioid use disorders in the United States, 2004-2013.","volume":"314","author":"Saloner","year":"2015","journal-title":"JAMA"},{"issue":"5","key":"zoi180099r9","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1097\/ALN.0000000000000170","article-title":"Buprenorphine-naloxone therapy in pain management.","volume":"120","author":"Chen","year":"2014","journal-title":"Anesthesiology"},{"issue":"7","key":"zoi180099r10","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1176\/appi.ps.201700315","article-title":"Buprenorphine use and spending for opioid use disorder treatment: trends from 2003 to 2015.","volume":"69","author":"Roberts","year":"2018","journal-title":"Psychiatr Serv"},{"issue":"4","key":"zoi180099r11","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1097\/MLR.0000000000000703","article-title":"Impact of Medicaid expansion on Medicaid-covered utilization of buprenorphine for opioid use disorder treatment.","volume":"55","author":"Wen","year":"2017","journal-title":"Med Care"},{"issue":"7","key":"zoi180099r13","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1097\/MLR.0000000000000727","article-title":"Patterns of buprenorphine-naloxone treatment for opioid use disorder in a multistate population.","volume":"55","author":"Saloner","year":"2017","journal-title":"Med Care"},{"key":"zoi180099r14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.drugalcdep.2016.04.033","article-title":"Impact of prescription drug monitoring programs and pill mill laws on high-risk opioid prescribers: a comparative interrupted time series analysis.","volume":"165","author":"Chang","year":"2016","journal-title":"Drug Alcohol Depend"},{"issue":"10","key":"zoi180099r16","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1377\/hlthaff.2015.0290","article-title":"California\u2019s early ACA expansion increased coverage and reduced out-of-pocket spending for the state\u2019s low-income population.","volume":"34","author":"Golberstein","year":"2015","journal-title":"Health Aff (Millwood)"},{"issue":"1, pt 1","key":"zoi180099r20","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1111\/j.1475-6773.2011.01314.x","article-title":"Interaction terms in nonlinear models.","volume":"47","author":"Karaca-Mandic","year":"2012","journal-title":"Health Serv Res"},{"issue":"2","key":"zoi180099r21","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1111\/j.0006-341X.2000.00645.x","article-title":"A note on robust variance estimation for cluster-correlated data.","volume":"56","author":"Williams","year":"2000","journal-title":"Biometrics"},{"issue":"2","key":"zoi180099r22","doi-asserted-by":"publisher","first-page":"597","DOI":"10.22237\/jmasm\/1257035100","article-title":"New effect size rules of thumb.","volume":"8","author":"Sawilowsky","year":"2009","journal-title":"J Mod Appl Stat Methods"},{"issue":"1","key":"zoi180099r23","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1002\/pam.21961","article-title":"Early impacts of the Affordable Care Act on health insurance coverage in Medicaid expansion and non-expansion states.","volume":"36","author":"Courtemanche","year":"2017","journal-title":"J Policy Anal Manage"},{"issue":"1","key":"zoi180099r24","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1111\/hesr.2014.49.issue-1","article-title":"Generalizing observational study results: applying propensity score methods to complex surveys.","volume":"49","author":"Dugoff","year":"2014","journal-title":"Health Serv Res"},{"issue":"12","key":"zoi180099r27","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.1377\/hlthaff.2017.0925","article-title":"The effect of Medicaid on medication use among poor adults: evidence from Oregon.","volume":"36","author":"Baicker","year":"2017","journal-title":"Health Aff (Millwood)"},{"key":"zoi180099r29","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.drugalcdep.2017.07.015","article-title":"Trends in insurance coverage and treatment among persons with opioid use disorders following the Affordable Care Act.","volume":"179","author":"Feder","year":"2017","journal-title":"Drug Alcohol Depend"},{"issue":"4","key":"zoi180099r30","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1377\/hlthaff.2016.1141","article-title":"States with prescription drug monitoring mandates saw a reduction in opioids prescribed to Medicaid enrollees.","volume":"36","author":"Wen","year":"2017","journal-title":"Health Aff (Millwood)"},{"issue":"1","key":"zoi180099r32","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1097\/JAN.0000000000000160","article-title":"Nurse practitioner prescriptive authority for buprenorphine: from DATA 2000 to CARA 2016.","volume":"28","author":"Fornili","year":"2017","journal-title":"J Addict Nurs"},{"issue":"8","key":"zoi180099r34","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1377\/hlthaff.2017.0083","article-title":"The Affordable Care Act reduced socioeconomic disparities in health care access.","volume":"36","author":"Griffith","year":"2017","journal-title":"Health Aff (Millwood)"},{"issue":"10","key":"zoi180099r35","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1056\/NEJMsa1612890","article-title":"Health and access to care during the first 2 years of the ACA Medicaid expansions.","volume":"376","author":"Miller","year":"2017","journal-title":"N Engl J Med"},{"key":"zoi180099r3","volume-title":"A Majority Staff Report of the Committee on Homeland Security and Governmental Affairs United States Senate. Drugs for Dollars: How Medicaid Fuels the Opioid Epidemic","year":"2018"},{"key":"zoi180099r5","volume-title":"Medicaid Expansion Dramatically Increased Coverage for People With Opioid-Use Disorders, Latest Data Show","author":"Broaddus","year":"2018"},{"key":"zoi180099r12","volume-title":"Medicaid Coverage of Effective Treatment for Opioid Use Disorder Trends in State Buprenorphine Prescriptions and Spending Since 2011","author":"Cope","year":"2017"},{"key":"zoi180099r28","doi-asserted-by":"crossref","DOI":"10.3386\/w23342","volume-title":"The Effect of Public Insurance Expansions on Substance Use Disorder Treatment: Evidence From the Affordable Care Act","author":"Maclean","year":"2017"},{"key":"zoi180099r31","year":"2017"},{"key":"zoi180099r33","volume-title":"Medicaid and the Opioid Epidemic","author":"Medicaid Payment Advisory Committee","year":"2017"},{"key":"zoi180099r1","unstructured":"ClarkeTC, WardBW, NorrisT, SchillerJS. Early release of selected estimates based on data from the January-September 2016 National Health Interview Survey. https:\/\/www.cdc.gov\/nchs\/data\/nhis\/earlyrelease\/earlyrelease201702.pdf. Accessed July 12, 2018."},{"key":"zoi180099r4","unstructured":"Goodman-BaconA, SandoeE. Did Medicaid expansion cause the opioid epidemic? there\u2019s little evidence that it did. https:\/\/www.healthaffairs.org\/do\/10.1377\/hblog20170823.061640\/full\/. Published 2018. Accessed March 1, 2018."},{"key":"zoi180099r15","unstructured":"Centers for Disease and Control and Prevention. Analyzing prescription data and morphine milligram equivalents (MME). September 2017. https:\/\/www.cdc.gov\/drugoverdose\/resources\/data.html. Accessed May 16, 2018."},{"key":"zoi180099r17","unstructured":"US Census Bureau. American Community Survey (ACS), 2018. https:\/\/www.census.gov\/programs-surveys\/acs\/. Accessed July 3, 2018."},{"key":"zoi180099r18","unstructured":"US Department of Health and Human Services. HRSA Data Warehouse; Area Health Resource File: 2018. https:\/\/datawarehouse.hrsa.gov\/topics\/ahrf.aspx. Accessed July 3, 2018."},{"key":"zoi180099r19","unstructured":"Centers for Disease Control and Prevention. Drug Overdose Death Data. 2018. https:\/\/www.cdc.gov\/drugoverdose\/data\/statedeaths.html. Accessed July 3, 2018."},{"key":"zoi180099r25","unstructured":"Centers for Disease and Control and Prevention. Annual surveillance report of drug-related risks and outcomes. https:\/\/stacks.cdc.gov\/view\/cdc\/47832. Published 2017. Accessed March 1, 2018."},{"key":"zoi180099r26","unstructured":"FinleyA. Does Medicaid spur opioid abuse? Wall Street Journal. https:\/\/www.wsj.com\/articles\/does-medicaid-spur-opioid-abuse-1506289279. Published September 24, 2017. Accessed March 1, 2018."}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/\/jamanetworkopen\/article-pdf\/1\/4\/e181588\/17309610\/saloner_2018_oi_180099.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,20]],"date-time":"2019-02-20T21:37:34Z","timestamp":1550698654000},"score":1,"resource":{"primary":{"URL":"http:\/\/jamanetworkopen.jamanetwork.com\/article.aspx?doi=10.1001\/jamanetworkopen.2018.1588"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,17]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,8,3]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2018.1588","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,17]]}}}